Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer

IF 4.4 Q1 CHEMISTRY, INORGANIC & NUCLEAR EJNMMI Radiopharmacy and Chemistry Pub Date : 2024-07-24 DOI:10.1186/s41181-024-00286-8
Herlinde Dierick, Laurent Navarro, Hannelore Ceuppens, Thomas Ertveldt, Ana Rita Pombo Antunes, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot, Matthias D’Huyvetter, Tony Lahoutte, Vicky Caveliers, Jessica Bridoux
{"title":"Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer","authors":"Herlinde Dierick,&nbsp;Laurent Navarro,&nbsp;Hannelore Ceuppens,&nbsp;Thomas Ertveldt,&nbsp;Ana Rita Pombo Antunes,&nbsp;Marleen Keyaerts,&nbsp;Nick Devoogdt,&nbsp;Karine Breckpot,&nbsp;Matthias D’Huyvetter,&nbsp;Tony Lahoutte,&nbsp;Vicky Caveliers,&nbsp;Jessica Bridoux","doi":"10.1186/s41181-024-00286-8","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Radiofluorination of single domain antibodies (sdAbs) via <i>N</i>-succinimidyl-4-[<sup>18</sup>F]fluorobenzoate ([<sup>18</sup>F]SFB) has shown to be a promising strategy in the development of sdAb-based PET tracers. While automation of the prosthetic group (PG) [<sup>18</sup>F]SFB production, has been successfully reported, no practical method for large scale sdAb labelling has been reported. Therefore, we optimized and automated the PG production, enabling a subsequently efficient manual conjugation reaction to an anti-fibroblast activation protein (FAP)-α sdAb (4AH29) and an anti-folate receptor (FR)-α sdAb (2BD42). Both the alpha isoform of FAP and the FR are established tumour markers. FAP-α is known to be overexpressed mainly by cancer-associated fibroblasts in breast, ovarian, and other cancers, while its expression in normal tissues is low or undetectable. FR-α has an elevated expression in epithelial cancers, such as ovarian, brain and lung cancers. Non-invasive imaging techniques, such as PET-imaging, using tracers targeting specific tumour markers can provide molecular information over both the tumour and its environment, which aides in the diagnosis, therapy selection and assessment of the cancer treatment.</p><h3>Results</h3><p>[<sup>18</sup>F]SFB was synthesized using a fully automated three-step, one-pot reaction. The total procedure time was 54 min and results in [<sup>18</sup>F]SFB with a RCP &gt; 90% and a RCY d.c. of 44 ± 4% (n = 13). The manual conjugation reaction after purification produced [<sup>18</sup>F]FB-sdAbs with a RCP &gt; 95%, an end of synthesis activity &gt; 600 MBq and an apparent molar activity &gt; 10 GBq/µmol. Overall RCY d.c., corrected to the trapping of [<sup>18</sup>F]F<sup>−</sup> on the QMA, were 9% (n = 1) and 5 ± 2% (n = 3) for [<sup>18</sup>F]FB-2BD42 and [<sup>18</sup>F]FB-4AH29, respectively.</p><h3>Conclusion</h3><p>[<sup>18</sup>F]SFB synthesis was successfully automated and upscaled on a Trasis AllInOne module. The anti-hFAP-α and anti-hFR-α sdAbs were radiofluorinated, yielding similar RCYs d.c. and RCPs, showing the potential of this method as a generic radiofluorination strategy for sdAbs. The radiofluorinated sdAbs showed a favourable biodistribution pattern and are attractive for further characterization as new PET tracers for FAP-α and FR-α imaging.</p></div>","PeriodicalId":534,"journal":{"name":"EJNMMI Radiopharmacy and Chemistry","volume":null,"pages":null},"PeriodicalIF":4.4000,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11269545/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Radiopharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s41181-024-00286-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Radiofluorination of single domain antibodies (sdAbs) via N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) has shown to be a promising strategy in the development of sdAb-based PET tracers. While automation of the prosthetic group (PG) [18F]SFB production, has been successfully reported, no practical method for large scale sdAb labelling has been reported. Therefore, we optimized and automated the PG production, enabling a subsequently efficient manual conjugation reaction to an anti-fibroblast activation protein (FAP)-α sdAb (4AH29) and an anti-folate receptor (FR)-α sdAb (2BD42). Both the alpha isoform of FAP and the FR are established tumour markers. FAP-α is known to be overexpressed mainly by cancer-associated fibroblasts in breast, ovarian, and other cancers, while its expression in normal tissues is low or undetectable. FR-α has an elevated expression in epithelial cancers, such as ovarian, brain and lung cancers. Non-invasive imaging techniques, such as PET-imaging, using tracers targeting specific tumour markers can provide molecular information over both the tumour and its environment, which aides in the diagnosis, therapy selection and assessment of the cancer treatment.

Results

[18F]SFB was synthesized using a fully automated three-step, one-pot reaction. The total procedure time was 54 min and results in [18F]SFB with a RCP > 90% and a RCY d.c. of 44 ± 4% (n = 13). The manual conjugation reaction after purification produced [18F]FB-sdAbs with a RCP > 95%, an end of synthesis activity > 600 MBq and an apparent molar activity > 10 GBq/µmol. Overall RCY d.c., corrected to the trapping of [18F]F on the QMA, were 9% (n = 1) and 5 ± 2% (n = 3) for [18F]FB-2BD42 and [18F]FB-4AH29, respectively.

Conclusion

[18F]SFB synthesis was successfully automated and upscaled on a Trasis AllInOne module. The anti-hFAP-α and anti-hFR-α sdAbs were radiofluorinated, yielding similar RCYs d.c. and RCPs, showing the potential of this method as a generic radiofluorination strategy for sdAbs. The radiofluorinated sdAbs showed a favourable biodistribution pattern and are attractive for further characterization as new PET tracers for FAP-α and FR-α imaging.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
单结构域抗体的通用半自动化放射性荧光策略:用于癌症中成纤维细胞活化蛋白-α或叶酸受体-α过表达的 PET 成像的[18F]FB 标记单结构域抗体。
背景:通过 N-琥珀酰亚胺基-4-[18F]氟苯甲酸酯([18F]SFB)对单域抗体(sdAbs)进行放射性氟化已被证明是开发基于 sdAb 的 PET 示踪剂的一种有前途的策略。虽然已有成功的报道称人工基团(PG)[18F]SFB 生产实现了自动化,但还没有报道过用于大规模 sdAb 标记的实用方法。因此,我们对 PG 的生产进行了优化并实现了自动化,这样就能对抗成纤维细胞活化蛋白(FAP)-α sdAb(4AH29)和抗叶酸受体(FR)-α sdAb(2BD42)进行高效的人工共轭反应。FAP 的α异构体和 FR 都是公认的肿瘤标志物。众所周知,FAP-α 主要在乳腺癌、卵巢癌和其他癌症的癌相关成纤维细胞中过表达,而在正常组织中的表达很低或检测不到。FR-α在卵巢癌、脑癌和肺癌等上皮癌中的表达量较高。使用针对特定肿瘤标记物的示踪剂进行 PET 成像等非侵入性成像技术可提供肿瘤及其环境的分子信息,有助于诊断、治疗选择和癌症治疗评估:结果:[18F]SFB 是通过全自动三步一步反应合成的。结果:[18F]SFB 是采用全自动三步一步反应合成的,整个过程耗时 54 分钟,合成的[18F]SFB RCP > 90%,RCY d.c. 为 44 ± 4%(n = 13)。纯化后的人工共轭反应产生的[18F]FB-sdAbs 的 RCP > 95%,合成末活性 > 600 MBq,表观摩尔活性 > 10 GBq/µmol。根据[18F]F-在 QMA 上的俘获进行校正后,[18F]FB-2BD42 和[18F]FB-4AH29 的总体 RCY d.c. 分别为 9% (n = 1)和 5 ± 2%(n = 3):结论:[18F]SFB 合成在 Trasis AllInOne 模块上成功实现了自动化和升级。对抗 hFAP-α 和抗 hFR-α sdAbs 进行了放射性氟化,得到了相似的 RCYs d.c.和 RCPs,显示了该方法作为 sdAbs 通用放射性氟化策略的潜力。放射性氟化的 sdAbs 显示出良好的生物分布模式,作为 FAP-α 和 FR-α 成像的新 PET 示踪剂,具有进一步表征的吸引力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.20
自引率
8.70%
发文量
30
审稿时长
5 weeks
期刊最新文献
Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation? DESI-TQ-MS imaging for ex vivo brain biodistribution assessment: evaluation of LBT-999, a ligand of the dopamine transporter (DAT) Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma Scalability study on [133La]LaCl3 production with a focus on potential clinical applications
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1